Trial Profile
Pharmacokinetic and Pharmacodynamic Evaluation of Etonogestrel Dose Escalation With Efavirenz-based Antiretroviral Therapy in HIV-infected Ugandan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2023
Price :
$35
*
At a glance
- Drugs Etonogestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 10 Mar 2023 Status changed from active, no longer recruiting to completed.
- 29 Jun 2020 Planned End Date changed from 1 Jul 2023 to 1 Jan 2023.
- 29 Jun 2020 Planned primary completion date changed from 1 Mar 2021 to 1 Jan 2021.